Request for Information-Pancreatic Cancer Primary Care Case Finding Data Search_英国招投标_中文版

• 首页 > 英国 > Request for Information-Pancreatic Cancer Primary Care Case Finding Data Search

加载中...

Request for Information-Pancreatic Cancer Primary Care Case Finding Data Search

发布时间	所属地区	所属机构	语言
2024年10月10日	--	--	英语 (English) 中文

Published date: 10 October 2024

Open early engagement - This means that a procurement idea is currently active, it is in the early stage of development and judging interest from potential suppliers.

Watch this notice Print this notice

Contract summary

Industry

Research and development consultancy services - 73200000

Social research services - 79315000

Location of contract

LS1 4AP

Procurement reference

CF-2645700D0O000000rwimUAA

Published date

10 October 2024

Closing date

25 October 2024

Contract type

Service contract

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

This is a Request for Information (RFI) to inform the proposed pilot for "Pancreatic Cancer Primary Care Case-finding Data Searches" where we are requesting future potential suppliers to complete the RFI document which can be found in the Documents section on Atamis. The purpose of this RFI is to gauge market interest and gain feedback via the RFI response form.
Please note that this is not a procurement exercise but a means of collecting information from the market to help us inform the Statement of Requirements/Specification for any future procurement opportunity.
The National Institute for Health and Care Excellence (NICE) recommends (NG12) urgent abdominal imaging for people who are aged 60 and over with new-onset diabetes (NOD) and weight loss. Evidence suggests currently only 3.5% of people who meet these criteria are being referred for an ultrasound or CT scan within 30 days.
There is an intention to run a pilot with the aim to improve the implementation of NG12 by searching patient GP records to identify people aged 60 and over with new-onset diabetes (NOD) and weight loss and invite them for a series of tests to check for early signs of pancreatic cancer. Case finding is expected to lead to a 2.6% - 4.7% impact on pancreatic cancer staging. If this pilot is effective, it could have a significant impact on diagnosis and thus survivability of pancreatic cancer in the future. If diagnosed early (stages 1-2) patients have a greater chance or receiving curative treatment.